
Marijuana has been reclassified as having moderate to low addiction potential, “expanding patients’ access to treatments and empowering doctors to make better-informed healthcare decisions,” acting attorney general Todd Blanche said.
It was earlier classified as “Schedule I,” a category for drugs with “no currently accepted medical use and a high potential for abuse” that includes heroin and methamphetamine, according to the US Drug Enforcement Agency (DEA).
It has now been moved to the third rung of the five-level Drug Schedule.
The justice department said today’s move followed up on president Donald Trump’s executive order in December on increasing medical marijuana research.